Test tubes about mpox virus are seen in this illustration taken on May 23, 2022. China's top drug regulator has recently approved clinical trials of a mpox vaccine developed by the domestic drugmaker Sinopharm, adding to a growing number of homegrown candidates in the pipeline, according to the company. The vaccine candidate from Sinopharm has proved safe and effective during …
China Daily| Updated :2024-09-11 The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company. The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to …
The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company. The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role …